Oncotarget

View Archive »

About The Cover

The cover for issue 35 of Oncotarget features Figure 3, "Surface plasmon resonance (SPR) analysis of Oridonin binding to AKT1," from Sun, et al.

Table of Contents

Editorial

https://doi.org/10.18632/oncotarget.22067

23846-23847
PDF  |  How to cite

Research Papers

https://doi.org/10.18632/oncotarget.24748

23848-23859
Abstract  |  PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.24794

23860-23877
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.24378

23878-23889
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release

https://doi.org/10.18632/oncotarget.25156

23890-23899
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.25199

23900-23914
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.23673

23915-23922
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.25246

23923-23943
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.24050

23944-23959
Abstract  |  PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.25251

23960-23974
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.25252

23975-23986
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.25253

23987-23999
Abstract  |  PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.25257

24000-24013
Abstract  |  PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.25265

24014-24027
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.25288

24028-24040
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.25275

24041-24053
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.25307

24054-24068
Abstract  |  PDF  |  Full Text  |  How to cite

https://doi.org/10.18632/oncotarget.25290

24069-24080
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.25300

24081-24096
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.25303

24097-24108
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.25313

24109-24121
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.24517

24122-24139
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

https://doi.org/10.18632/oncotarget.25329

24140-24154
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Meta-Analysis

https://doi.org/10.18632/oncotarget.23816

24155-24167
Abstract  |  PDF  |  Full Text  |  How to cite

Clinical Research Papers

https://doi.org/10.18632/oncotarget.24202

24168-24177
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite


Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC